Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4595289 | 0.95 | NAAA (0.50) | NAAAALDH1A1DNM1CA12CA1 | |
| SCHEMBL1814598 | 0.93 | NAAA (0.53) | NAAAALDH1A1DNM1TSHRHTR2C | |
| SCHEMBL17193651 | 0.93 | NAAA (0.53) | NAAAALDH1A1DNM1TSHRHTR2C | |
| SCHEMBL18119729 | 0.93 | NAAA (0.53) | NAAAALDH1A1DNM1TSHRHTR2C | |
| SCHEMBL21526190 | 0.93 | NAAA (0.53) | NAAAALDH1A1DNM1TSHRHTR2C | |
| SCHEMBL27467292 | 0.92 | NAAA (0.51) | NAAAALDH1A1DNM1TSHRHTR2C | |
| SCHEMBL28092339 | 0.92 | NAAA (0.51) | NAAAALDH1A1DNM1TSHRHTR2C | |
| SCHEMBL4098848 | 0.89 | CA1 (0.42) | NAAAALDH1A1DNM1CA12CA1 | |
| SCHEMBL672097 | 0.82 | CA1 (0.58) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL19152428 | 0.81 | CA1 (0.42) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080254198-A1 | Method of Preparing Creatine Ester Salts and Uses Thereof | BIO-ENGINEERED SUPPLEMENTS & NUTRITION, INC. (US) | 2008-10-16 | — | — | US | claimed |
| US-20230159442-A1 | CELLULAR ENERGY COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | VIREO SYSTEMS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230159442-A1 | CELLULAR ENERGY COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | VIREO SYSTEMS, INC. (US) | 2023-05-25 | — | — | US | disclosed |
| CN-101274943-B | Synthetic method for disodium creatine phosphate | SHANGHAI CIRUI MEDICINE TECHNOLOGY LTD | 2011-05-11 | — | — | CN | disclosed |
| CN-101274943-A | Synthetic method for disodium creatine phosphate | SHANGHAI CIRUI MEDICINE TECHNO (CN) | 2008-10-01 | — | — | CN | disclosed |
| WO-2007146088-A1 | SALICYL ALCOHOL CREATINE PHOSPHATE PRODRUGS, COMPOSITIONS AND USES THEREOF | XENOPORT, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20070281910-A1 | Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof | XENOPORT, INC. | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159442-A1 | CELLULAR ENERGY COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF | PC, PCK2, MAVS | NAAA 3098/4885ALDH1A1 2051/4885DNM1 789/4885 |
| US-20070281910-A1 | Salicyl alcohol creatine phosphate prodrugs, compositions and uses thereof | CKMT1A; CKMT1B, SUCNR1, FABP3 | NAAA 895/4885ALDH1A1 537/4885DNM1 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.